Highly complementary Williston Basin and Delaware Basin assets enhance Crestwood’s competitive positioning in its core growth basins...
Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc. PR Newswire LAVAL, Quebec, April 25, 2013...
Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously...
Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common...
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical...
SECURITIES AND EXCHANGE COMMISSION Washingt...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM N-1A REGIST...
Valeant Pharmaceuticals’ (VRX) proposed acquisition of Obagi Medical Products, Inc. (OMPI) received a boost with Merz Pharma Group opting...
Among the companies with shares expected to actively trade in Monday's session are Lufkin Industries Inc. (LUFK), Obagi Medical Products Inc...
By Tess Stynes Merz Pharma Group withdrew its roughly $385 million offer to acquire Obagi Medical Products Inc. (OMPI), citing Valeant...
Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products PR Newswire FRANKFURT, Germany, April 8, 2013 FRANKFURT, Germany, April 8...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.